©2022 Australasian Society of Clinical Immunology and Allergy (ASCIA)
ABN 45 615 521 452


Medical Product Supply Updates

In response to the COVID-19 outbreak many suppliers of medical products are working to ensure the continuity of supply to patients in Australia and New Zealand, whilst protecting the health of their employees. ASCIA is monitoring the situation and will post updates for suppliers on this page to keep ASCIA members updated. The information on this page should not be shared in social media posts.

AMSL - Allergen Immunotherapy

pdfAMSL Business Update135.94 KB

Bayer - Novalac Allergy Formula

pdfNovalac Allergy HCP Supply Update June 2020104.47 KB

Gamma Allergy - Allergen Immunotherapy

pdfGamma Allergy Delivery and Supply Status 2020043092.98 KB

Mylan - EpiPen

pdfEpiPen_supply_update_90320157.49 KB

Nutricia - Amino Acid and Extensively Hydrolysed Formula

pdfCOVID-19_Hospital Comms (Nutricia)78.23 KB

Sanofi - Hydroxychloroquine (Plaquenil)

pdfPlaquenil HCP Letter 25 Mar 2020110.09 KB 

pdfHydroxychloroquine factsheet 2020 PBS402.71 KB

Seqirus - Allergen Immunotherapy

pdfSeqirus Australia Pty Ltd AU Supply Update107.84 KB

Stallergenes Greer - Allergen Immunotherapy

pdfSTG Greer Update March 2020 150.22 KB 

Content updated June 2020